Pharmacogenomics is not a new science: for decades it has been known that genes play a role in an individual's susceptibility to disease and their response to a drug. Techniques such as linkage analysis and testing for single-gene diseases have ensured the role of genetics in diagnosis and drug discovery and development. And now, single-nucleotide polymorphisms (SNPs) look set to build on this.

This content is only available as a PDF.